EXHIBIT 10.12 EXECUTIVE CHANGE OF CONTROL AGREEMENT This Agreement is made as of August 16, 2001, between Angiotech Pharmaceuticals (U.S.), Inc., a Washington corporation having an office at Suite 6501, 701 5th Avenue, Seattle, Washington, 98104...Executive Change of Control Agreement • December 27th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • Washington
EXHIBIT 10.15 EXECUTIVE CHANGE OF CONTROL AGREEMENT This Agreement is made as of August 23, between Angiotech Pharmaceuticals (U.S.), Inc., a Washington corporation having an office at Suite 6501, 701 5th Avenue, Seattle, Washington, 98104 ("Angiotech...Executive Change of Control Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • Washington
EXHIBIT 10.14 EXECUTIVE CHANGE OF CONTROL AGREEMENT This Agreement is made as of August 20, between Angiotech Pharmaceuticals (U.S.), Inc., a Washington corporation having an office at Suite 6501, 701 5th Avenue, Seattle, Washington, 98104 ("Angiotech...Executive Change of Control Agreement • October 30th, 2002 • Angiotech Pharmaceuticals Inc • Pharmaceutical preparations • Washington